VCL-HB01

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameVCL-HB01
Drug Alias NameHSV-2 DNA vaccine单纯疱疹病毒DNA疫苗 - VicalHerpes simplex DNA vaccineHSV-2 glycoprotein D vaccineVCL-HB01
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes Genitalis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVical Incorporated
Active IndicationsN/A
Inactive IndicationsHerpes Genitalis

Other Information

ATC CodeN/A
Related LinksN/A